These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 30175519)
1. Clinical and pathological features of idiopathic membranous nephropathy in young people. Lin C; Zheng D; Wang Y; Wang S Nephrology (Carlton); 2019 Jun; 24(6):599-604. PubMed ID: 30175519 [TBL] [Abstract][Full Text] [Related]
2. Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy. Kumar V; Ramachandran R; Kumar A; Nada R; Suri D; Gupta A; Kohli HS; Gupta KL; Jha V Nephrology (Carlton); 2015 Aug; 20(8):572-5. PubMed ID: 26194981 [TBL] [Abstract][Full Text] [Related]
3. The relationship of anti-phospholipase A2 receptor antibody and C5a complement with disease activity and short-term outcome in idiopathic membranous nephropathy. Chi JN; Lai TS; Wu CF; Fu TY; Chou YH; Chiu YL; Lin WC; Chiang WC; Chen YM; Wu MS J Formos Med Assoc; 2019 May; 118(5):898-906. PubMed ID: 30639075 [TBL] [Abstract][Full Text] [Related]
4. Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China. Zhang D; Zou J; Zhang C; Zhang W; Lin F; Jiang G Med Sci Monit; 2018 Jul; 24():5076-5083. PubMed ID: 30032157 [TBL] [Abstract][Full Text] [Related]
5. [The relationship between anti-phospholipase A2 receptor antibody and idiopathic membranous nephropathy]. Lin W; Li H; Li X; Qin Y; Su Y; Yu Y; Guan Y; Duan L; Li Y; Wen Y; Li X Zhonghua Nei Ke Za Zhi; 2015 Sep; 54(9):783-8. PubMed ID: 26674797 [TBL] [Abstract][Full Text] [Related]
6. Relationship between the status of phospholipase A2 receptor and prognosis of idiopathic membranous nephropathy. Li YQ; Liu ZZ; Lin KX; Liu RH; Ni L; Liu GX; Lan HY; Shi YJ Nephrology (Carlton); 2020 Feb; 25(2):144-149. PubMed ID: 31226230 [TBL] [Abstract][Full Text] [Related]
7. Association of serum mannose-binding lectin, anti-phospholipase A2 receptor antibody and renal outcomes in idiopathic membranous nephropathy and atypical membranous nephropathy: a single center retrospective cohort study. Zhao Y; Cai M; Jiang Z; Dong B; Yan Y; Wang Y; Zuo L Ren Fail; 2022 Dec; 44(1):428-433. PubMed ID: 35272568 [TBL] [Abstract][Full Text] [Related]
8. Clinical value of renal phospholipase A2 receptor deposit in the prognosis evaluation and treatment options of idiopathic membranous nephropathy: A retrospective cohort study. Xie Z; Dong W; Li Z; Chen Y; Song L; Li R; Wu Y; Fu L; Liang H; Tao Y; Xie J; Wang W; Liu S; Ye Z; Shi W; Liang X Nephrology (Carlton); 2020 Mar; 25(3):219-229. PubMed ID: 31900967 [TBL] [Abstract][Full Text] [Related]
9. Effect of Glomerular Mannose-Binding Lectin Deposition on the Prognosis of Idiopathic Membranous Nephropathy. Zhang Y; Liu Y; Liang L; Liu L; Tang X; Tang L; Chen P; Chen J; Wang Z; Cao W; Chen Q; Zhao N; Xu D Kidney Blood Press Res; 2020; 45(5):713-726. PubMed ID: 32894840 [TBL] [Abstract][Full Text] [Related]
10. Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN). Radice A; Trezzi B; Maggiore U; Pregnolato F; Stellato T; Napodano P; Rolla D; Pesce G; D'Amico M; Santoro D; Londrino F; Ravera F; Ortisi G; Sinico RA Autoimmun Rev; 2016 Feb; 15(2):146-54. PubMed ID: 26527329 [TBL] [Abstract][Full Text] [Related]
11. Phospholipase-A2 receptor antibody, 24 hours proteinuria, and serum albumin as indicators of cyclophosphamide efficacy in idiopathic membranous nephropathy. Xiao C; Liu Y; Zhang X; Luo L; Li X; Wang T; Tian Z; Qin X; Liu J J Clin Lab Anal; 2020 Sep; 34(9):e23368. PubMed ID: 32449206 [TBL] [Abstract][Full Text] [Related]
12. Anti-Phospholipase A2 Receptor (Anti-PLA2R) Antibody in Diagnosis and Treatment of Idiopathic Membranous Nephropathy: A Single-Center Observational Study in China. Guo N; Cao Y; Dai H; Yuan L; Shi L; Zhang Y Med Sci Monit; 2019 Dec; 25():9364-9368. PubMed ID: 31813930 [TBL] [Abstract][Full Text] [Related]
13. [Diagnostic value of renal phospholipase A2 receptor and serum anti-phospholipase A2 receptor antibody in membranous nephropathy]. Wu X; Wen S; Zhu X; Yuan S; Xu X; Yang D; Sun L; Liu H; Liu F Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Apr; 42(4):395-399. PubMed ID: 28490696 [TBL] [Abstract][Full Text] [Related]
14. Response to immunosuppressive therapy in PLA Wang J; Xie Q; Sun Z; Xu N; Li Y; Wang L; Liu S; Xue J; Hao CM BMC Nephrol; 2017 Jul; 18(1):227. PubMed ID: 28693446 [TBL] [Abstract][Full Text] [Related]
15. Detection and clinical significance of glomerular M-type phospholipase A Liu H; Luo W; Gong S; Ding X Intern Med J; 2016 Nov; 46(11):1318-1322. PubMed ID: 27554390 [TBL] [Abstract][Full Text] [Related]
16. Analysis of Glomerular IgG Subclasses Switch in Idiopathic Membranous Nephropathy Classified by Glomerular Phospholipase A2 Receptor Antigen and Serum Antibody. Cui HY; Li C; Li H; Wen YB; Duan L; Li Y; Yan XW; Hu YT; Chen LM; Li XM Dis Markers; 2021; 2021():9965343. PubMed ID: 34497677 [TBL] [Abstract][Full Text] [Related]
17. Negative anti-phospholipase A2 receptor antibody status at three months predicts remission in primary membranous nephropathy. Stefan G; Stancu S; Zugravu A; Popa O; Zubidat D; Petre N; Mircescu G Ren Fail; 2022 Dec; 44(1):258-268. PubMed ID: 35172682 [TBL] [Abstract][Full Text] [Related]
18. Outcomes of primary membranous nephropathy based on serum anti-phospholipase A2 receptor antibodies and glomerular phospholipase A2 receptor antigen status: a retrospective cohort study. Yin P; Wang J; Liang W; Zhan L; Liu Y; Lin J; Chen X; He Y; Jian H; Xie Z; Tan X; Ye Q; Huang F Ren Fail; 2020 Nov; 42(1):675-683. PubMed ID: 32674643 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases. Radice A; Pieruzzi F; Trezzi B; Ghiggeri G; Napodano P; D'Amico M; Stellato T; Brugnano R; Ravera F; Rolla D; Pesce G; Giovenzana ME; Londrino F; Cantaluppi V; Pregnolato F; Volpi A; Rombolà G; Moroni G; Ortisi G; Sinico RA J Nephrol; 2018 Apr; 31(2):271-278. PubMed ID: 29081027 [TBL] [Abstract][Full Text] [Related]
20. Clinical features, course and prognosis of idiopathic membranous nephropathy depending on the presence of antibodies against M-type phospholipase A2 receptor. Jatem Escalante E; Segarra Medrano A; Carnicer Cáceres C; Martín-Gómez MA; Salcedo Allende MT; Ostos Roldan H; Agraz Pamplona I Nefrologia; 2015; 35(5):479-86. PubMed ID: 26306972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]